These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19786462)

  • 1. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
    Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
    Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
    Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
    BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.
    Jernström H; Chu W; Vesprini D; Tao Y; Majeed N; Deal C; Pollak M; Narod SA
    Mol Genet Metab; 2001 Feb; 72(2):144-54. PubMed ID: 11161840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.
    Hoyo C; Grubber J; Demark-Wahnefried W; Lobaugh B; Jeffreys AS; Grambow SC; Marks JR; Keku TO; Walther PJ; Schildkraut JM
    J Natl Med Assoc; 2009 Jul; 101(7):711-6. PubMed ID: 19634593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.
    Gao Y; Katki H; Graubard B; Pollak M; Martin M; Tao Y; Schoen RE; Church T; Hayes RB; Greene MH; Berndt SI
    Int J Cancer; 2012 Jul; 131(2):E105-13. PubMed ID: 21932422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.
    Jung SY; Barrington WE; Lane DS; Chen C; Chlebowski R; Corbie-Smith G; Hou L; Zhang ZF; Paek MS; Crandall CJ
    Menopause; 2017 Mar; 24(3):288-298. PubMed ID: 27749737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
    Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ
    Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated free IGF2 levels in localized, early-stage breast cancer in women.
    Espelund U; Cold S; Frystyk J; Ørskov H; Flyvbjerg A
    Eur J Endocrinol; 2008 Nov; 159(5):595-601. PubMed ID: 18719053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort.
    DeLellis K; Ingles S; Kolonel L; McKean-Cowdin R; Henderson B; Stanczyk F; Probst-Hensch NM
    Br J Cancer; 2003 Jan; 88(2):277-82. PubMed ID: 12610514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal women.
    Jung SY; Vitolins MZ; Paskett ED; Chang S
    J Gerontol A Biol Sci Med Sci; 2015 Apr; 70(4):495-502. PubMed ID: 25238773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
    ; Key TJ; Appleby PN; Reeves GK; Roddam AW
    Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study.
    Adachi Y; Nojima M; Mori M; Himori R; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A;
    Cancer Prev Res (Phila); 2020 Apr; 13(4):385-394. PubMed ID: 31996369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
    Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
    Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men.
    Fowke JH; Signorello LB; Chang SS; Matthews CE; Buchowski MS; Cookson MS; Ukoli FM; Blot WJ
    Cancer; 2006 Nov; 107(10):2361-7. PubMed ID: 17031814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
    Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of environmental temperature on IGF1, IGF2, and IGF type I receptor expression in rainbow trout (Oncorhynchus mykiss).
    Gabillard JC; Weil C; Rescan PY; Navarro I; Gutiérrez J; Le Bail PY
    Gen Comp Endocrinol; 2003 Sep; 133(2):233-42. PubMed ID: 12928012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women.
    Fehringer G; Ozcelik H; Knight JA; Paterson AD; Boyd NF
    Breast Cancer Res Treat; 2009 Jul; 116(2):413-23. PubMed ID: 18785005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
    Pearce CL; Doherty JA; Van Den Berg DJ; Moysich K; Hsu C; Cushing-Haugen KL; Conti DV; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Pharoah PD; Song H; Kjaer SK; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Sieh W; Gronwald J; Medrek K; Jakubowska A; Lubinski J; Chenevix-Trench G; ; Beesley J; Webb PM; Berchuck A; Schildkraut JM; Iversen ES; Moorman PG; Edlund CK; Stram DO; Pike MC; Ness RB; Rossing MA; Wu AH
    Hum Mol Genet; 2011 Jun; 20(11):2263-72. PubMed ID: 21422097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women.
    Slattery ML; Baumgartner KB; Byers T; Guiliano A; Sweeney C; Herrick J; Curtin K; Murtaugh M; Wolff R
    Cancer Causes Control; 2005 Dec; 16(10):1147-57. PubMed ID: 16215864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.